Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A
about
Insights into antibody catalysis: structure of an oxygenation catalyst at 1.9-angstrom resolutionHyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designIn situ click chemistry: from small molecule discovery to synthetic antibodiesAntibody C219 recognizes an alpha-helical epitope on P-glycoproteinStructural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23Identification of the collagen-binding site of the von Willebrand factor A3-domainThree-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibodyStructure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1Molecular Basis of Recognition of Human Osteopontin by 23C3, a Potential Therapeutic Antibody for Treatment of Rheumatoid ArthritisStructural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing AntibodiesStructure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola VirusSomatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 NeutralizationIn silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive TumorsCrystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigenCompared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR dataStructure of an Fab fragment against a C-terminal peptide of hCG at 2.0 A resolutionMode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling studyCrystal structure of Taq DNA polymerase in complex with an inhibitory Fab: the Fab is directed against an intermediate in the helix-coil dynamics of the enzymeA hot spot of binding energy in a hormone-receptor interfaceAntigen mobility in the combining site of an anti-peptide antibody.Crystallization and preliminary X-ray diffraction data of the Fab fragment of a monoclonal antibody against apamin, a bee venom neurotoxin.Docking of combinatorial peptide libraries into a broadly cross-reactive human IgM.Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin.Synthetic antibody libraries focused towards peptide ligands.The recognition of proteins and peptides by antibodies.High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinitySynthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation.Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatisStructure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y.Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. I. High resolution epitope mapping and characterization of monoclonal antibody binding sitesComplete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient.Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidaseContribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.Epitope mapping of the gastrin-releasing peptide/anti-bombesin monoclonal antibody complex by proteolysis followed by matrix-assisted laser desorption ionization mass spectrometry.Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an AntibodyDevelopment of a receptor peptide antagonist to human gamma-interferon and characterization of its ligand-bound conformation using transferred nuclear Overhauser effect spectroscopy.
P2860
Q24605184-7C9399AD-B77A-41E8-AA2C-3EFF1079C6D2Q24679395-8B71615B-3963-403E-81A2-A92788CD4729Q27013640-FBCB505D-9A05-43DA-A060-ABC94B17D6ECQ27620436-739F6C93-22D4-4F41-86B6-E703F07A4449Q27624926-11B07180-662C-4FCC-ACDB-61487F83E1FCQ27628691-14799858-41E3-41F9-9007-76D88ECC080FQ27642149-9F5AB542-0A8C-4C81-88B4-08B2663737CDQ27643117-158F005F-5E50-48DB-A7E8-68E55CBBFD62Q27651515-6C475BA6-1A15-4265-B258-797D36DE1AB8Q27671374-5BFE164D-B8D3-4FDE-A5A9-3D568AD1E317Q27676230-FC66B0DF-952D-417D-9170-6C9357BC8CE4Q27677117-9B2CB3F5-5DC7-4FDE-A407-C044E4A16F99Q27678257-0A82E19D-CCD2-4343-989F-9675DDA12C27Q27731338-A11A07A6-CDD1-4016-9700-C28E097D1D96Q27731780-BA40C011-C0FE-4247-A045-B7EF4F4F8B3CQ27734932-16447E52-A473-40C4-AF35-0CF9E3271EE8Q27765157-4A617160-A8FC-4A65-804B-E283A706E1FCQ27765326-BBF11C49-50F1-4226-A246-227E626BC530Q27765686-A4410B7D-BF1B-45ED-B4CC-8ADAC195462EQ29547547-EB22E812-A79F-45ED-BFDE-6FEC3FE984DCQ30358772-5D91A316-CFAA-4A4B-9577-D439A55AC008Q31111018-1C95ED12-3086-4E86-BFB8-B3ADC69E97A4Q31922982-05973E0E-755E-4444-BAAF-2053DA8DD461Q33217116-DF22F1D4-1A9C-4C28-BA1A-BB33471EE716Q33326776-A74705AC-4565-464C-8050-94E45D4B0941Q33993576-AC088800-E65A-4737-B4EA-7989A4204188Q34018972-2389D5FE-942C-4127-91A1-D4F742CAFF1BQ35136110-41334D7C-18E2-40FF-B786-8CAE4D513AC5Q35711994-071A40F4-870D-418E-8374-E5DD3048128AQ35778506-9B7F9929-F2EC-4587-94D6-CD018A8D3609Q36016347-AF7E0E8F-51FE-4A0B-8D9B-C2D4EFB0E7BDQ36085843-F7E9526D-7485-4D77-8D86-CD62E294B510Q36224266-2B755A59-D5BA-438E-9C07-4CB2EEF283CAQ36248082-B3D2AD31-D1FE-493E-B58B-9F0010A32F67Q36263296-ECDFFEF5-0810-4400-B8CC-4866D3C643D2Q36278518-65535654-594F-4DEC-9399-16CDE0A05D7EQ36278829-46F4CEF1-6811-40FF-BFDD-D91C95CF4631Q36279375-47733F12-49D1-4269-B24F-C561AF7C18FEQ36433887-8F5EB9EC-E849-45A2-9BA8-1857995D09F9Q36700753-30C0D4C2-5160-44A0-9DFB-2DEEC3ED83D2
P2860
Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@ast
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@en
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@nl
type
label
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@ast
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@en
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@nl
prefLabel
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@ast
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@en
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@nl
P2093
P3181
P356
P1433
P1476
Crystal structures of an antib ...... with peptide antigen at 2.8 A
@en
P2093
I A Wilson
R A Lerner
R L Stanfield
T M Fieser
P3181
P356
10.1126/SCIENCE.2333521
P407
P577
1990-05-11T00:00:00Z